European thyroid journalHumansSeleniumDouble-Blind MethodGraves DiseaseFemale
Selenium supplementation in individuals with newly diagnosed Graves' hyperthyroidism: a double-blind, multi-centre RCT.
Per K Cramon, Kristian H Winther, Victor B Boesen, Camilla B Larsen, Jakob B Bjorner, Selma F Nordqvist, Julie L Forman, Anne B Juul, Pernille Bach-Mortensen, Nils Knudsen, Runa L Nolsøe, Tina Vilsbøll, Alin Andries, Jeppe Gram, Birte Nygaard
Published: 202610.1530/ETJ-25-0264
Abstract
Purpose: We examined the effect of selenium vs placebo on remission rate and quality of life (QoL) in the Graves' selenium supplementation (GRASS) trial (ID: NCT01611896). Methods: Double-blinded, placebo-controlled, multi-centre trial in individuals…
Preview only. Read the full abstract at the source